Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00121368
Status:
COMPLETED
Last Update Posted:
2013-11-25
First Post:
2005-07-15
Brief Title:
GN Tobacco Use Survey
Sponsor:
NICHD Global Network for Womens and Childrens Health
Organization:
NICHD Global Network for Womens and Childrens Health
Study Overview
Official Title:
Survey on Tobacco Use in the GN Sites
Status:
COMPLETED
Status Verified Date:
2013-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Smoking can contribute to many health problems for mothers and their babies In developing countries there is little information about the number of pregnant women that smoke and the reasons why some pregnant women choose to smoke The purpose of this multi-site tobacco use survey is to obtain information on knowledge attitudes and behaviors among pregnant women in diverse populations regarding tobacco products
Detailed Description:
Smoking is regarded as one of the few potentially preventable factors associated with low birth weight very preterm birth and perinatal death In an effort to determine the prevalence of tobacco use smoking and smokeless tobacco and to collect relevant data in support of a potential smoking prevention or cessation intervention a multi-site tobacco use survey is being conducted in several countries The survey will be used to obtain information on knowledge attitudes and behaviors among pregnant women in diverse populations regarding tobacco products
The primary outcome is tobacco use status during pregnancy Secondary outcomes include knowledge and attitudes regarding tobacco products health hazards of tobacco use and environmental tobacco smoke ETS exposure
Sample size of 750 per country was calculated under the assumptions that the prevalence of tobacco use could be as low as 005 with a coefficient of variation of approximately 15 and a prevalence of 010 with a CV of approximately 11
The primary outcome is tobacco use status during pregnancy Secondary outcomes include knowledge and attitudes regarding tobacco products health hazards of tobacco use and environmental tobacco smoke ETS exposure
Sample size of 750 per country was calculated under the assumptions that the prevalence of tobacco use could be as low as 005 with a coefficient of variation of approximately 15 and a prevalence of 010 with a CV of approximately 11
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None